EVFM - ネオセティクス (Evofem Biosciences Inc.)

EVFMのニュース

   Why Evofem Biosciences Shares Are Plunging Today?  2022/10/12 18:17:25 Benzinga
Evofem Biosciences Inc''s (OTC: EVFM ) recently completed the Phase 3 EVOGUARD trial evaluating Phexxi vaginal gel (EVO100) to prevent chlamydia and gonorrhea infection in women but did not achieve its endpoints. CEO Saundra Pelletier, trial investigator Brandi Howard and study statistician Clint Dart all blamed the loss on COVID-19''s impact on infection rates … Full story available on Benzinga.com
   Stifel Downgrades Evofem Biosciences Inc to Hold  2022/10/12 17:39:02 Investing.com
https://www.investing.com/news/pro/stifel-downgrades-evofem-biosciences-inc-to-hold-432SI-2910857
   Evofem''s Phexxi fails in phase 3 trial to prevent chlamydia, gonorrhea in women  2022/10/12 09:55:36 Seeking Alpha
Evofem Biosciences (EVFM) said a phase 3 trial of EVO100 (vaginal gel Phexxi) to prevent chlamydia and gonorrhea infection in women did not achieve its goals and that the company will…
   Evofem Biosciences, Inc. (EVFM: OTCQB) | OTC Markets Group Welcomes New OTCQB Companies – October 10  2022/10/10 11:00:00 OTC Markets
   Evofem Biosciences Says Vaginal Contraceptive Gel Phexxi Approved In Nigeria  2022/10/06 13:11:59 RTT News
Evofem Biosciences, Inc. (EVFM) announced Thursday that its hormone-free contraceptive vaginal gel Phexxi has been approved by the Nigerian Regulatory Agency NAFDAC (National Agency for Food and Drug Administration and Control). This is the first regulatory approval outside the U.S.
   Evofem (EVFM) And The Phexxi Launch  2022/09/12 15:08:08 Seeking Alpha
An excessive rate of spending has put Evofem in a terrible financial position. Phexxi is a product with a suboptimal profile, and sales figures support this conclusion. Read more here.
   Evofem Biosciences Inc PT Lowered to $0.55 at Morgan Stanley  2022/09/09 06:59:11 Investing.com
https://www.investing.com/news/pro/evofem-biosciences-inc-pt-lowered-to-055-at-morgan-stanley-432SI-2888860
   Pleasing stocks: Akebia Therapeutics, Inc. (NASDAQ:AKBA -3.27%), Evofem Biosciences, Inc. (NASDAQ:EVFM -2.72%)  2022/08/31 03:42:19 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Pleasing stocks: Akebia Therapeutics, Inc. (NASDAQ:AKBA -3.27%), Evofem Biosciences, Inc. (NASDAQ:EVFM -2.72%) appeared first on Stocks Equity .
   This stocks will Fire Up Your investment: Evofem Biosciences, Inc. (NASDAQ:EVFM 7.35%), Denison Mines Corp. (AMEX:DNN 16.36%)  2022/08/25 01:25:55 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post This stocks will Fire Up Your investment: Evofem Biosciences, Inc. (NASDAQ:EVFM 7.35%), Denison Mines Corp. (AMEX:DNN 16.36%) appeared first on Stocks Equity .
   Overwhelming stocks: Evofem Biosciences, Inc. (NASDAQ:EVFM -5.94%), Tantech Holdings Ltd (NASDAQ:TANH -7.13%)  2022/08/22 00:51:36 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Overwhelming stocks: Evofem Biosciences, Inc. (NASDAQ:EVFM -5.94%), Tantech Holdings Ltd (NASDAQ:TANH -7.13%) appeared first on Stocks Equity .
   EVFM Stock Heats Up Following ''Huge Win.'' 7 Things to Know.  2022/01/12 20:05:33 InvestorPlace
Today, investors in women''s health company Evofem Biosciences and EVFM stock are dancing, following revised birth control regulations.
   Evofem scores a “huge win” with revised birth control guidelines - Stifel  2022/01/12 18:00:39 Seeking Alpha
Evofem Biosciences <> has gained over a tenth after the company highlighted the impact on its birth control gel Phexxi post new federal guidance requiring the payors to…
   Why Are Evofem Biosciences Shares Rising On Wednesday?  2022/01/12 15:18:27 Benzinga
Evofem Biosciences Inc (NASDAQ: EVFM ) shares are trading higher after the Health Resources and Services Administration (HRSA) and the U.S. Department of Labor issued updated guidance related to contraceptive access. The new guidance specifies that most insurers and pharmacy benefit managers (PBMs) must provide coverage, with no out-of-pocket costs to women, for FDA-approved contraceptive products, like Phexxi, prescribed by healthcare providers. "We Full story available on Benzinga.com
   Evofem gains amid prospects for its contraceptive gel under new govt. guidance  2022/01/12 14:01:40 Seeking Alpha
Micro-cap stock Evofem Biosciences (EVFM) has gained ~30.0% on above-average volume after the company highlighted how a newly issued guidance from the U.S
   Thinking about buying stock in Jaguar Health, Evofem Biosciences, Adverum Biotechnologies, FREYR Battery, or Planet Labs?  2022/01/12 13:35:00 Benzinga
NEW YORK , Jan. 12, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for JAGX, EVFM, ADVM, FREY, and PL. Full story available on Benzinga.com

calendar